
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Oncol., 29 March 2022
Sec. Gastrointestinal Cancers: Gastric and Esophageal Cancers
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.888600
This article is a correction to:
Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
A Corrigendum on:
Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
By Yang B, Chen Q, Wan C, Sun S, Zhu L, Zhao Z, Zhong W and Wang B (2021). Front. Oncol. 11:709486. doi: 10.3389/fonc.2021.709486
An author name was incorrectly spelled as “Bangmang Wang”. The correct spelling is “Bangmao Wang”.
In the published article, there was an error in Affiliation 1. Instead of “Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin Institute of Digestive Disease, Tianjin, China”, it should be “Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Institute of Digestive Disease, Tianjin, China”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
In the published article, there was an error in Affiliation 2. Instead of “Department of Digestive Diseases, General Hospital of Jincheng, Tianjin, China”, it should be “Department of Digestive Diseases, Jincheng General Hospital, Shanxi, China”.
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: esophageal squamous cell carcinoma (ESCC), transgelin, epithelial mesenchymal transition (EMT), invasion, metastasis, proliferation
Citation: Yang B, Chen Q, Wan C, Sun S, Zhu L, Zhao Z, Zhong W and Wang B (2022) Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition. Front. Oncol. 12:888600. doi: 10.3389/fonc.2022.888600
Received: 03 March 2022; Accepted: 09 March 2022;
Published: 29 March 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Yang, Chen, Wan, Sun, Zhu, Zhao, Zhong and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bangmao Wang, bXdhbmcwMkB0bXUuZWR1LmNu; Weilong Zhong, emhvbmd3ZWlsb25nQHRtdS5lZHUuY24=
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.